PX-866 with Cetuximab (Erbitux) going into Phase Two
coloCan
CSN Member Posts: 1,944 Member
"PX-866 is a pan inhibitor of the PI-3K/PTEN/AKT pathway, a critical cell signalling that is activated in many types of cancer"-(CRC being one of them)
Its made by Oncothyreon Inc and I read about it at prenewswire.com
with an upcoming meeting of ASCO expect more in the news as drug manufacturers generally present their latest stuff at such conventions
Its made by Oncothyreon Inc and I read about it at prenewswire.com
with an upcoming meeting of ASCO expect more in the news as drug manufacturers generally present their latest stuff at such conventions
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122.3K Cancer specific
- 2.8K Anal Cancer
- 451 Bladder Cancer
- 310 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 399 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 678 Leukemia
- 799 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 240 Multiple Myeloma
- 7.2K Ovarian Cancer
- 66 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 740 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards